We are live on ! Find out more
BIOX icon

Bioceres Crop Solutions

8 hedge funds and large institutions have $1.34M invested in Bioceres Crop Solutions in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.69% less ownership

Funds ownership: 1.39%0.7% (-0.69%)

47% less funds holding

Funds holding: 158 (-7)

49% less capital invested

Capital invested by funds: $2.63M → $1.34M (-$1.29M)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 7

Holders
8
Holders Change
-7
Holders Change %
-46.67%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
3
Closed
7
Calls
Puts
Net Calls
Net Calls Change

BIOX Hedge Fund Activity: Q2 2019 in Review

8 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Bioceres Crop Solutions (BIOX) for Q2 2019, worth a combined $1.34M — down 49% from $2.63M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of BIOX and 0 opened new positions — a net loss of 7 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Bluefin Capital Management, adding an estimated $2.56K. The largest seller was Kepos Capital, cutting an estimated $371K.

  • 8 institutional investors held Bioceres Crop Solutions (BIOX) as of Q2 2019, down from 15 in Q1 2019.
  • Funds reported $1.34M of Bioceres Crop Solutions stock for Q2 2019, down 49% quarter-over-quarter.
  • 0 funds opened new Bioceres Crop Solutions positions in Q2 2019 and 7 closed out, a net change of -7 holders.
  • The largest Bioceres Crop Solutions buyer in Q2 2019 was Bluefin Capital Management, an estimated $2.56K added.
  • The largest Bioceres Crop Solutions seller in Q2 2019 was Kepos Capital, an estimated $371K sold.

Based on aggregated 13F filings for Q2 2019.